The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Risk of missing advanced stage or high grade tumors during active surveillance (AS) even in favorable-risk prostate cancer (PC).
Jeri Kim
No relevant relationships to disclose
John Francis Ward
No relevant relationships to disclose
Curtis A. Pettaway
No relevant relationships to disclose
Xuemei Wang
No relevant relationships to disclose
Deborah A. Kuban
No relevant relationships to disclose
Steven J. Frank
No relevant relationships to disclose
Andrew Lee
No relevant relationships to disclose
Louis L. Pisters
No relevant relationships to disclose
Surena F. Matin
No relevant relationships to disclose
Jay Bakul Shah
No relevant relationships to disclose
Jose A. Karam
No relevant relationships to disclose
Brian Francis Chapin
No relevant relationships to disclose
John N. Papadopoulos
No relevant relationships to disclose
Mary F. Achim
No relevant relationships to disclose
Karen Elizabeth Hoffman
No relevant relationships to disclose
Thomas J. Pugh
No relevant relationships to disclose
Seungtaek Choi
No relevant relationships to disclose
Christopher Logothetis
No relevant relationships to disclose
Patricia Troncoso
No relevant relationships to disclose
John W. Davis
No relevant relationships to disclose